Recruiting
Dilated cardiomyopathy+1
RecruitingStudy on Early Use of Candesartan vs Placebo for People with Genetic Risk of Dilated Cardiomyopathy
Registered drug
Study on Early Use of Candesartan vs Placebo for People with Genetic Risk of Dilated Cardiomyopathy
Registered drug
- Disease:Dilated cardiomyopathyGene mutation
- Substances:Candesartan Cilexetil
Countries:
The Netherlands
The Netherlands- Participants:18–64 years
- Substances:Candesartan Cilexetil
- Sponsor:Fundacion Para La Investigacion Biomedica Del Hospital Universitario Puerta De Hierro Majadahonda

